CASI icon

CASI Pharmaceuticals

58 hedge funds and large institutions have $80.8M invested in CASI Pharmaceuticals in 2018 Q2 according to their latest regulatory filings, with 27 funds opening new positions, 17 increasing their positions, 3 reducing their positions, and 14 closing their positions.

Holders
58
Holders Change
+13
Holders Change %
+28.89%
% of All Funds
1.33%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
%
% of All Funds
0.05%
New
27
Increased
17
Reduced
3
Closed
14
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
LTFS
51
Ladenburg Thalmann Financial Services
Florida
$8K 2,046
PIA
52
Piedmont Investment Advisors
North Carolina
$7K 866 +866 New
Bank of Montreal
53
Bank of Montreal
Ontario, Canada
$3K 354 +354 New
AG
54
Advisor Group
Arizona
$1K 90
Goldman Sachs
55
Goldman Sachs
New York
-178,063 Closed
LCM
56
Laurion Capital Management
New York
-55,729 Closed
Renaissance Technologies
57
Renaissance Technologies
New York
-41,800 Closed
ECM
58
Element Capital Management
New York
-29,279 Closed
PIM
59
Penobscot Investment Management
Massachusetts
-27,000 Closed
JG
60
Jefferies Group
New York
-27,000 Closed
BCM
61
BlueCrest Capital Management
Jersey
-26,709 Closed
Citadel Advisors
62
Citadel Advisors
Florida
-20,097 Closed
Verition Fund Management
63
Verition Fund Management
Connecticut
-15,835 Closed
AGM
64
Alpine Global Management
New York
-11,954 Closed
GC
65
Guggenheim Capital
Illinois
-10,949 Closed
IWM
66
IHT Wealth Management
Illinois
-7,000 Closed
CIBC Private Wealth Group
67
CIBC Private Wealth Group
Georgia
-100 Closed
SPIA
68
Steward Partners Investment Advisory
New York
-45 Closed
IA
69
IFP Advisors
Florida
$0 2
CPIG
70
Chicago Partners Investment Group
Illinois
$0 27
RFM
71
Royal Fund Management
Florida
$0 9
FWM
72
Focused Wealth Management
New York
$0 45